Preclinical and phase I clinical profile of Virobay's cathepsin S inhibitors for neuropathic pain Dec. 10, 2014
Phase I data for the Notch signaling inhibitor BMS-906024 in patients with T-ALL and T-LL Dec. 9, 2014
Phase III data presented from the MOBILITY trial evaluating sarilumab in patients with RA Dec. 9, 2014
DPI-289, a dual delta agonist/mu antagonist, shows promise in models of Parkinson's disease Dec. 5, 2014
RSS